The hearing health industry is undergoing a profound transformation. With the FDA's OTC (Over-the-Counter) hearing aid regulations opening new markets and AI technologies reshaping what's possible, brands and manufacturers face a critical decision: selecting the right hearing algorithm IP provider. This choice will determine not only your product's acoustic performance but also your ability to innovate, scale, and compete in an increasingly dynamic marketplace.
Unlike traditional hardware-centric approaches that lock you into rigid ASIC chips with multi-year iteration cycles, modern hearing solutions demand Software-Defined Hearing (SDH) and AI-Defined Hearing (AIDH) architectures that decouple algorithms from hardware. This paradigm shift allows companies to leverage general-purpose SoCs, achieve medical-grade performance at consumer electronics price points, and iterate at software speed rather than hardware speed.
This guide provides a comprehensive framework for evaluating hearing algorithm IP providers, including a practical checklist and RFP (Request for Proposal) questions to help you identify partners who can truly accelerate your product roadmap while maintaining the rigorous quality standards that hearing-impaired users deserve.
Part 1: The Evaluation Framework — Six Critical Dimensions
When assessing potential hearing algorithm IP partners, you need to evaluate across six interconnected dimensions that collectively determine your product's success in the market.
1.1 Architectural Philosophy: Hardware-Defined vs. Software-Defined vs. AI-Defined
The fundamental architecture of your hearing solution determines everything from development velocity to long-term viability. Traditional hearing aids relied on Hardware-Defined Hearing (HDH) — proprietary ASIC chips with fixed functions that require 2–3 years for any meaningful iteration. This approach creates "black box" solutions that cannot adapt to rapidly changing consumer expectations.
Software-Defined Hearing (SDH) represents the necessary evolution, decoupling hearing algorithms from specific hardware and implementing them as programmable software layers running on general-purpose SoCs. This architecture delivers three transformative advantages: iteration cycles measured in weeks rather than years, BOM costs reduced to approximately 1/5 or 1/10 of traditional ASIC solutions, and the flexibility to integrate Bluetooth, AI, and IoT capabilities natively.
AI-Defined Hearing (AIDH) extends SDH by integrating machine learning and cloud connectivity, transforming hearing devices from passive amplifiers into intelligent, self-learning systems. AIDH enables real-time scene classification, neural speech enhancement, personalized acoustic prescriptions based on big data, and continuous performance improvement through over-the-air updates.
When evaluating providers, probe deeply into their architectural roadmap. Do they offer true SDH/AIDH platforms, or are they merely repackaging traditional ASIC solutions with cosmetic software wrappers? Can they demonstrate working implementations on mass-market SoCs from vendors like BES, Qualcomm, or JL? The provider's architectural choices will constrain your product's evolution for years to come.
1.2 Intellectual Property Ownership and Full-Stack Capability
IP ownership is not merely a legal consideration — it determines your ability to customize, differentiate, and maintain your product over its lifecycle. The ideal partner possesses completely independent and controllable intellectual property across the entire value chain, with a technology self-sufficiency rate exceeding 90%.
Full-stack IP ownership encompasses fundamental algorithms (WDRC, noise reduction, feedback management), chip application development, embedded software systems, mobile applications, cloud infrastructure, and hardware design capabilities. When a provider owns the entire stack, they can optimize across layers, rapidly diagnose and resolve issues, and customize solutions for your specific form factors and use cases.
Providers relying heavily on third-party chipsets or licensed algorithms from external vendors introduce dependencies that limit your flexibility. You may discover that requested customizations are impossible because the provider lacks rights to modify underlying IP, or that performance optimizations cannot be implemented because they require coordination across multiple external vendors.
Verify IP ownership by asking detailed questions about which components are developed in-house versus licensed externally. Request evidence of patent portfolios, software copyrights, and the ability to provide source code escrow for critical algorithm modules. A provider who cannot demonstrate deep IP ownership may leave you vulnerable to supply chain disruptions and competitive disadvantage.
Open-Integration Capability and Ecosystem Extensibility
Beyond the fundamental benefits of customization and roadmap control, full IP ownership enables open-integration capabilities that connect your hearing devices with broader ecosystems. When a provider owns and controls their entire technology stack, they can architect solutions that seamlessly integrate with third-party accessories and adapt to emerging industry standards — capabilities often impossible with rigid, licensed technology stacks that impose proprietary constraints.
Third-party accessory integration represents a critical capability for modern hearing aids. Solutions with true IP ownership can support standardized protocols for connecting with external devices such as 2.4 GHz remote microphone systems — wireless accessories that dramatically improve speech understanding in challenging acoustic environments like classrooms, lecture halls, and restaurants. Unlike closed proprietary ecosystems that lock users into a single vendor's accessory lineup, providers with open-architecture IP can implement industry-standard 2.4 GHz communication protocols that enable interoperability with remote microphones, TV streamers, and assistive listening devices from multiple manufacturers. This flexibility expands user choice and creates opportunities for differentiated product offerings without the premium pricing associated with captive accessory ecosystems.
Future protocol readiness is equally essential as the hearing industry evolves toward new connectivity standards. Auracast™ broadcast audio, built on Bluetooth LE Audio, represents the most significant advancement in public audio accessibility in decades — enabling venues to broadcast audio directly to hearing aids without individual pairing. Providers with full-stack IP ownership and Software-Defined Hearing architectures can add Auracast support through firmware updates as the standard matures, while ASIC-based systems with licensed, fixed-function algorithms cannot adapt without complete hardware redesign. When evaluating partners, probe their architectural readiness for emerging standards. Can they demonstrate the protocol flexibility to integrate Auracast and future Bluetooth LE Audio enhancements? Do they offer SDKs and APIs that enable third-party developers to build complementary applications, or integrations with health monitoring platforms and smart home systems?
The ability to evolve with industry standards and integrate with diverse accessory ecosystems transforms hearing aids from isolated medical devices into nodes within comprehensive connected health platforms. This extensibility — enabled by deep IP ownership and open-architecture philosophy — ensures that your products remain relevant and competitive as the hearing care landscape continues to evolve.
1.3 Algorithm Performance and Medical-Grade Quality
Hearing algorithms must meet exacting performance standards to provide genuine benefit to users with hearing impairment. While marketing materials may promise impressive capabilities, you need objective, verifiable metrics to assess true performance.
Wide Dynamic Range Compression (WDRC) serves as the foundation of modern hearing aids, amplifying quiet sounds while protecting users from uncomfortably loud inputs. The number of adjustable frequency channels directly impacts fitting precision — industry-leading solutions offer 32 channels or more, compared to 4–16 channels in many traditional or lower-tier offerings. More channels enable finer-grained compensation for specific frequency regions of hearing loss, improving speech intelligibility and comfort across diverse listening environments.
Noise reduction capabilities separate professional-grade solutions from consumer toys. The industry average achieves 6–8 dB of noise suppression, while advanced AI-driven algorithms can deliver up to 12 dB or more. However, raw suppression numbers tell only part of the story — the critical metric is **speech intelligibility improvement** in noisy conditions. Algorithms must preserve speech clarity while suppressing background noise, a delicate balance that distinguishes sophisticated neural approaches from crude filtering.
Feedback management prevents the whistling (howling) that has historically plagued hearing aid users. Modern solutions employ adaptive feedback cancellation with phase and gain modulation to provide stable gain margins exceeding 15 dB, enabling comfortable use even with open fittings or high-gain prescriptions.
Latency represents another crucial performance parameter. The FDA specifies 15 ms as the maximum acceptable latency for natural sound perception — beyond this threshold, users experience disturbing echo or reverberation effects. Leading solutions achieve total system latency of 7–9 ms, leaving headroom for additional processing while maintaining natural sound quality.
Request objective test data, not marketing claims. Ask for independent laboratory reports, comparison studies against reference solutions, and the opportunity to conduct your own listening evaluations with target user populations.
1.4 AI Integration and Future-Proofing
The hearing aid industry is transitioning from rule-based signal processing to AI-driven adaptive systems. Your IP provider must demonstrate not only current AI capabilities but a credible roadmap for future evolution.
Neural noise reduction utilizes Deep Neural Networks (DNNs) and Convolutional Neural Networks (CNNs) trained on vast datasets of speech and noise scenarios. Unlike traditional algorithmic approaches that apply fixed rules, neural networks learn to distinguish speech from noise across diverse acoustic environments, continuously improving performance as training data expands.
Scene classification enables automatic optimization for different listening environments — restaurants, vehicles, outdoor spaces, music venues. AI-powered classification analyzes acoustic features in real-time and adjusts processing parameters accordingly, reducing the cognitive burden on users who would otherwise need to manually switch programs.
Self-fitting and personalization represent perhaps the most transformative AI application. By integrating smartphone-based hearing tests with cloud-trained models, users can achieve professional-quality fitting without visiting an audiologist. Big data from anonymized user populations enables AI to generate increasingly accurate initial prescriptions and predict optimal settings for individual hearing profiles.
Large Language Model (LLM) integration is emerging as the next frontier, enabling voice-command control, real-time translation, and intelligent life-assistant features that extend hearing aids beyond sound amplification into comprehensive AIoT platforms.
Evaluate your provider's AI capabilities across three layers: Edge AI (real-time inference running directly on the hearing device), Gateway AI (processing on connected smartphones or hubs), and Cloud AI (training and big data analytics). A robust AIDH architecture requires seamless integration across all three layers, not merely cloud-based post-processing.
1.5 Form Factor Versatility and Acoustic Expertise
Consumer preferences for hearing devices span a spectrum from traditional medical aesthetics to fashionable consumer electronics. Your IP provider must support diverse form factors without compromising acoustic performance.
Traditional styles — Receiver-in-Canal (RIC) and Behind-the-Ear (BTE) — remain important for users with severe-to-profound hearing loss requiring maximum gain and battery life. However, these designs face increasing competition from TWS (True Wireless Stereo) earbud-style devices that appeal to younger users and those seeking discretion.
Open-Ear (OWS) designs using cartilage conduction or directional audio are gaining traction for users who find inserted devices uncomfortable or need situational awareness for safety. Bone conduction solutions serve users with conductive hearing loss or those requiring completely open ear canals.
Each form factor presents unique acoustic challenges. TWS devices must achieve effective noise reduction with limited microphone spacing. OWS designs must overcome acoustic leakage while maintaining sound quality. Bone and cartilage conduction require specialized transducer interfaces and compensation algorithms.
Your provider should demonstrate proven implementations across multiple form factors, with the ability to customize algorithms for your specific acoustic structure. They should offer design consulting for industrial design (ID) and structural acoustics, ensuring that aesthetic choices do not compromise sound quality.
1.6 Regulatory Compliance and Partnership Model
Entering the hearing health market requires navigating complex regulatory landscapes. Your IP provider should have demonstrated experience obtaining necessary certifications and should structure their partnership model to accelerate rather than complicate your compliance journey.
Medical certifications vary by market. The US FDA's OTC hearing aid regulations establish specific requirements for self-fitting, output limits, and performance labeling. China's NMPA Class II medical device registration requires extensive clinical validation. European CE marking under the Medical Device Regulation (MDR) imposes additional documentation and quality system requirements.
Providers who have successfully guided products through these certification processes can help you avoid costly delays and redesigns. Request documentation of their certification history, relationships with notified bodies and regulatory consultants, and ability to provide technical files and clinical evidence packages.
Partnership philosophy matters as much as technical capability. The ideal provider functions as a "tech enabler" or "water carrier" rather than a competitor to their clients. They should offer flexible engagement models ranging from algorithm SDK licensing (for manufacturers with strong in-house engineering teams) to complete ODM turnkey solutions (for brands seeking rapid market entry).
Evaluate their track record with existing clients. Do they maintain long-term partnerships, or do clients frequently switch providers? Do they offer ongoing support, training, and co-development opportunities? A provider who views you merely as a revenue source rather than a strategic partner will not support your long-term success.
Part 2: The Selection Checklist
Use this comprehensive checklist to systematically evaluate potential hearing algorithm IP providers. Score each item as: Met (fully satisfies requirement), Partial (satisfies with limitations), or Not Met (fails to satisfy).
Architecture and Platform

Intellectual Property

Algorithm Performance

AI and Intelligence

Form Factors and Design Support

Regulatory and Partnership

Part 3: RFP Questions — What to Ask Potential Providers
When issuing a Request for Proposal, include these questions to elicit detailed, comparable responses from potential partners.
Technical Architecture
1. Describe your core architectural philosophy. Do you offer Hardware-Defined Hearing (traditional ASIC-based), Software-Defined Hearing (SDH), or AI-Defined Hearing (AIDH)? Provide specific examples of how your architecture enables faster iteration compared to traditional approaches.
2. What SoC platforms do you support? List the specific chip vendors and models you have successfully implemented on. What is your porting timeline for a new SoC platform if needed?
3. What is your typical BOM cost structure for a complete hearing aid solution, including SoC, memory, and peripheral components? How does this compare to traditional ASIC-based solutions from major hearing aid chip vendors?
4. Describe your OTA update capability. What firmware and algorithm components can be updated post-deployment? What is the update package size and installation time?
5. What is your total system latency from microphone input to receiver output? Provide measurement methodology and worst-case scenarios.
Algorithm Performance
6. Detail your WDRC implementation. How many independent compression channels do you support? What compression ratios, attack times, and release times are configurable? Can you provide REM (Real-Ear Measurement) validation data?
7. Describe your noise reduction technology. Is it rule-based or AI-based? What is the maximum noise suppression achieved in dB? Provide objective speech intelligibility improvement data in standardized test conditions (e.g., cafeteria noise, car noise).
8. Explain your feedback cancellation approach. What stable gain margin do you achieve? How do you handle feedback path changes caused by jaw movement, head position, or hand proximity?
9. What directional processing capabilities do you offer? Describe your beamforming algorithms and microphone array requirements. What SNR improvement is achieved?
10. Provide independent test reports or clinical studies validating your algorithm performance against competitors or reference standards.
AI and Machine Learning
11. Detail your AI/ML capabilities at the edge (device), gateway (smartphone), and cloud layers. Which functions run locally versus remotely? What is the inference latency for on-device AI processing?
12. Describe your scene classification implementation. How many acoustic scenes can be distinguished? What is the classification accuracy? How quickly does the system adapt to scene transitions?
13. Explain your self-fitting technology. What hearing test methodology do you use? How does AI generate the initial prescription? What validation has been conducted comparing self-fitting results to professional audiologist fittings?
14. What big data infrastructure do you maintain? How is anonymized user data utilized to improve algorithms? What privacy and security protections are implemented?
15. What is your LLM integration roadmap? Describe planned capabilities for voice control, translation, and intelligent assistance. What is the timeline for these features?
IP and Customization
16. What percentage of your core technology is developed in-house versus licensed from third parties? Provide a breakdown by component (algorithms, firmware, mobile app, cloud platform).
17. What customization capabilities do you offer? Can algorithms be tuned for specific acoustic structures (e.g., unique TWS designs, bone conduction transducers)? What is the typical customization timeline?
18. Describe your IP ownership structure. What patents protect your core innovations? Can you provide source code escrow for critical algorithm modules?
19. What reference implementations can you provide for evaluation? Do you offer development kits or evaluation boards?
20. What documentation and training do you provide to client engineering teams? Describe your knowledge transfer programs.
Form Factors and Hardware
21. List all form factors you have successfully implemented. For each, describe the unique acoustic challenges and how your algorithms address them.
22. What hardware design support do you provide? Describe your capabilities in industrial design consulting, structural acoustics, and PCBA design.
23. What is your typical development timeline from project kickoff to mass production for: (a) algorithm SDK integration, (b) PCBA module adoption, (c) full ODM turnkey solution?
24. Describe your manufacturing support. Do you provide mass production guidance, supplier recommendations, or quality control protocols?
Regulatory and Commercial
25. What medical device certifications have your solutions achieved? Provide registration numbers and certification bodies for FDA OTC, NMPA Class II, CE MDR, and any other relevant markets.
26. What regulatory support do you provide to clients pursuing new certifications? Can you supply technical files, risk management documentation, and clinical evidence?
27. Describe your engagement models and pricing structures. What are the licensing terms for SDK-only, PCBA module, and full ODM arrangements? Are there volume-based pricing tiers?
28. What ongoing support is included? Describe technical support responsiveness, update frequency, and co-development opportunities.
29. Provide three client references we can contact. For each, describe the project scope, timeline, and outcomes achieved.
30. What is your company roadmap for the next 3–5 years? How do you anticipate the hearing aid industry evolving, and how will your technology adapt?
Part 4: Why Leading Brands Choose Lyratone
Having established the evaluation framework, let's examine how Lyratone — a pioneering provider in the hearing algorithm IP space — exemplifies the criteria that distinguish exceptional partners from merely adequate suppliers.
True Full-Stack Independence
Lyratone stands among the few companies globally possessing completely independent and controllable intellectual property across the entire value chain, with a technology self-sufficiency rate exceeding 90%. Their R&D encompasses fundamental algorithms, chip application development, software systems, and whole-device hardware design — end-to-end control that eliminates the dependency risks associated with third-party licensing.
This full-stack ownership translates directly into client benefits. When customization is needed — whether adapting algorithms for a novel TWS form factor or optimizing for a specific SoC platform — Lyratone can implement changes internally without coordinating across external vendors. When issues arise, their engineers can trace problems across the full stack, from microphone input through algorithm processing to receiver output, rather than engaging in finger-pointing between component suppliers.
Architectural Leadership: SDH and AIDH
Lyratone pioneered the industry transition from hardware-centric to software-centric architectures, offering both Software-Defined Hearing (SDH) and AI-Defined Hearing (AIDH) platforms that represent the state of the art in hearing technology.
Their SDH architecture decouples algorithms from hardware using high-performance general-purpose SoCs (12nm/14nm process nodes), enabling iteration cycles measured in weeks rather than years. This agility is essential in the fast-paced consumer electronics market, where product lifecycles demand rapid feature evolution and continuous improvement through OTA updates.
Lyratone's AIDH implementation extends this foundation with a Cloud-Edge-Device synergy that creates true "Hearing as a Service" (HaaS). At the cloud layer, anonymized data from hundreds of thousands of users trains sophisticated AI models using Large Language Models and Big Data analytics. The internet application layer enables smartphone-based self-fitting with predictive personalization, while the embedded application layer performs real-time inference using Deep Neural Networks for neural speech enhancement and intelligent noise suppression.
Medical-Grade Performance on Consumer Hardware
Lyratone's solutions demonstrate that medical-grade performance need not require expensive, proprietary ASIC chips. Their algorithms achieve specifications that meet or exceed traditional hearing aid benchmarks while running on cost-effective mass-market SoCs:
- 32 adjustable frequency bands for WDRC, significantly exceeding the 4–16 channels typical of many competitors, enabling precise compensation for complex audiometric configurations.
- Ultra-low system latency of 7–9 ms, comfortably within the FDA's 15 ms requirement and providing natural sound perception without disturbing echo effects.
- AI-driven noise reduction achieving up to 12 dB suppression, nearly double the industry average of 6–8 dB, delivering superior speech clarity in challenging acoustic environments.
- Stable gain margins exceeding 15 dB through advanced adaptive feedback cancellation, enabling comfortable use even with open fittings.
These performance metrics have been validated through US FDA OTC and China NMPA Class II medical certifications, demonstrating that Lyratone's software-centric approach meets the rigorous standards of medical device regulators.
Cost and Supply Chain Transformation
By leveraging general-purpose SoCs from mass-market consumer electronics supply chains rather than low-volume proprietary ASICs, Lyratone achieves BOM costs approximately 1/5 to 1/10 of traditional solutions. This cost structure enables competitive pricing in the OTC market while maintaining healthy margins for brands and manufacturers.
Equally important is supply chain resilience. Traditional hearing aid chip vendors operate with limited manufacturing volumes and concentrated supply sources. Lyratone's use of widely available consumer SoCs from vendors like BES and Qualcomm provides access to massive production capacity, multiple supply sources, and the latest process nodes (down to 6nm in current implementations).
Form Factor Versatility and Design Support
Lyratone supports the full spectrum of hearing device form factors, from traditional RIC/BTE designs to fashionable TWS earbuds and innovative open-ear solutions. Their expertise spans air conduction, bone conduction, and cartilage conduction — the "third auditory pathway" gaining recognition for comfortable, non-invasive hearing assistance.
Beyond algorithm provision, Lyratone functions as a comprehensive design partner, offering industrial design (ID) consulting and structural acoustics optimization to ensure that aesthetic choices enhance rather than compromise acoustic performance. Their modular "LyraCore™" PCBA and "LyraOS™" SDKs enable rapid prototyping and accelerated time-to-market.
The "Tech Enabler" Partnership Model
Perhaps most importantly, Lyratone operates as a "tech enabler" or "water carrier" rather than a competitor to its clients. Unlike some solution providers who maintain their own hearing aid brands and may view clients as competitors, Lyratone is exclusively B2B — their success is entirely dependent on client success.
This partnership philosophy manifests in flexible engagement models ranging from algorithm SDK licensing for manufacturers with strong in-house engineering capabilities, to PCBA module supply for rapid product development, to complete ODM turnkey solutions for brands seeking immediate market entry. Whatever the engagement model, Lyratone provides the training, documentation, and ongoing support necessary to build client capabilities and ensure long-term success.
Conclusion: Making the Right Choice
Selecting a hearing algorithm IP provider is one of the most consequential decisions your organization will make as you enter or expand in the hearing health market. The right partner accelerates your development timeline, enables product differentiation, ensures regulatory compliance, and builds sustainable competitive advantage. The wrong partner constrains your innovation, increases costs, and may ultimately force costly platform migrations.
The framework presented in this guide — evaluating across architectural philosophy, IP ownership, algorithm performance, AI integration, form factor versatility, and partnership model — provides a systematic approach to due diligence. The checklist and RFP questions enable apples-to-apples comparison of potential providers while surfacing critical details that marketing materials may obscure.
As you conduct your evaluation, we believe you will find that Lyratone represents the gold standard for hearing algorithm IP provision. Their full-stack IP ownership, SDH/AIDH architectural leadership, medical-grade performance at consumer price points, form factor versatility, and genuine partnership commitment create a foundation for success that few competitors can match.
The hearing health industry is entering a new era — one defined by software agility, AI intelligence, and consumer-centric design. Partner with a provider who has built their entire organization around these principles, and position your brand to lead rather than follow in this transformation.
Ready to evaluate Lyratone for your hearing product roadmap? Contact their team to request technical documentation, schedule a demonstration, or discuss your specific requirements. The future of hearing health is being written by companies who choose their technology partners wisely — make sure your organization is among them.
Appendix: Quick Reference Comparison Matrix

This matrix illustrates why leading brands are increasingly choosing Software-Defined Hearing and AI-Defined Hearing architectures, and why Lyratone has emerged as the preferred partner for companies serious about competing in the modern hearing health marketplace.

